During the past decade, Albertinen Herz- und Gefäßzentrum conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Albertinen Herz- und Gefäßzentrum" are "Tricuspid Valve Insufficiency" (1 trials) and "Valve Disease, Heart" (1 trials). Many other conditions were trialed in "Albertinen Herz- und Gefäßzentrum" in a lesser frequency.

Most popular intervention types in "Albertinen Herz- und Gefäßzentrum" are "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Contour 3D Tricuspid Annuloplasty Ring" (1 trials), "Left-sided heart surgery" (1 trials), "Surgical Heart Valve Repair Products" (1 trials), "Surgical Heart Valve Replacement Products" (1 trials) and "Tricuspid valve repair" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albertinen Herz- und Gefäßzentrum" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Albertinen Herz- und Gefäßzentrum". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Albertinen Herz- und Gefäßzentrum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Albertinen Herz- und Gefäßzentrum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".